Article

Bladder Cancer Matters Podcast: Should Bladder Cancer Patients Work with an Oncology Social Worker?

The Bladder Cancer Advocacy Network's new podcast by, for, and about the bladder cancer community, "Bladder Cancer Matters," has a new episode available.

The Bladder Cancer Advocacy Network's new podcast by, for, and about the bladder cancer community, "Bladder Cancer Matters," has a new episode available.

In Episode 2 Part 1, host Rick Bangs chats with Dr. Heather Honoré Goltz. Rick and Heather discuss:

What oncology social work is and how it is different than other types of social work

How an oncology social worker can be helpful on a bladder cancer journey

Dr. Goltz is an Associate Professor of Social Work at the University of Houston-Downtown and a Research Investigator at the Michael E. DeBakey VA Medical Center. She is also the Chair of the Association of Oncology Social Workers Education Committee.

In case you missed it, you can catch Episode 1, Rick's interview with Dr. Ashish Kamat, "What's Up with Bladder Cancer and BCG?"

You can also listen and subscribe to this podcast through Apple Podcasts, Google Podcasts, Amazon Music Podcasts and more. If you subscribe through your favorite service, you'll be the first to know when a new episode is available.

Related Videos
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Image of man with black hair.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Image of bald man.
Image of a man with rectangular glasses and a goatee.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Related Content
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder cancer.
March 28th 2025

FDA Approves Imfinzi Therapy in Muscle Invasive Bladder Cancer

Ryan Scott
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder cancer.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Padcev plus Keytruda elicited responses in the first-line setting, with Padcev showing benefit in later lines, in metastatic urothelial carcinoma: © freshidea - stock.adobe.com.
March 22nd 2025

Padcev With or Without Keytruda Elicits Responses in Urothelial Cancer

Alex Biese
In metastatic urothelial carcinoma, Padcev plus Keytruda elicited responses in the first-line setting, with Padcev showing benefit in later lines.
cancer horizons podcast logo
December 20th 2023

FDA Approves 3 Treatments, Cancer Vaccine Shows Promise

Alex Biese Brielle Benyon
The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.
Illustration of bladder cancer.
March 14th 2025

Blue Light Cystoscopy Reduces Recurrence in High-Risk Bladder Cancer

Ryan Scott
Blue light cystoscopy had a statistically significant reduction in risk of recurrence versus white light cystoscopy in high-risk bladder cancer.
Illustration of bladder.
March 13th 2025

Antihistamines Associated With Bladder Cancer Survival, Progression Improvements

Alex Biese
Antihistamines are associated with improvement for patients with metastatic urothelial carcinoma receiving Tecentriq.